Feasibility, Safety and Impact of (18F)-FDG PET/CT in patients with pregnancy-associated cancer: experience of the French CALG (Cancer Associé à La Grossesse) network.

Marie DespierresAnne-Sophie BoudyLise SelleretJoseph GligorovSandrine RichardIsabelle ThomassinYohann DabiSonia ZilbermanCyril TouboulFrançoise MontraversKerrou KhaldounEmile Darai

Published in: Acta oncologica (Stockholm, Sweden) (2021)

(18F)-FDG PET/CT has a major impact on the management of pregnancy-associated cancers and does not appear to cause fetal side effects suggesting that the exam is feasible during pregnancy as maternal benefits outweigh fetal risks.

Keyphrases

papillary thyroid
pregnancy outcomes
squamous cell
preterm birth
childhood cancer
lymph node metastasis
physical activity
human health
pregnant women
risk assessment
body mass index